RETRACTED: Aerosolised liposomal Hamycin (cas 1403-71-0) for treatment of systemic Candida infections in mice
-
Add time:09/07/2019 Source:sciencedirect.com
This article has been retracted by agreement between the journal Chief Editor, Patrik Bavoil, Elsevier and Wiley-Blackwell. The author has been notified. Please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).Reason: The retraction has been agreed due to significant overlap between this article and the following article published in Antimicrobial Agents and Chemotherapy: 'Aerosolized Amphoterin B-Liposomes for Treatment of Systemic Candida Infections in Mice' by Brian E. Gilbert, Philip R. Wyde, Gabriel Lopez-Berestein and Samuel Z. Wilson. Antimicrob. Agents Chemother., 38 (1994) 356–359.The retraction has also been published by Wiley-Blackwell, doi:10.1111/j.1574-695X.2008.00433.x.
We also recommend Trading Suppliers and Manufacturers of Hamycin (cas 1403-71-0). Pls Click Website Link as below: cas 1403-71-0 suppliers
Prev:RETRACTED: Hamycin (cas 1403-71-0) treatment of candidiasis in normal and diabetic rats
Next:Photophysics of triphenylphosphines and their oxides: role of dimethylamino substituents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- RETRACTED: Hamycin (cas 1403-71-0) treatment of candidiasis in normal and diabetic rats09/06/2019
- Regular ArticleMannose-Coated Liposomal Hamycin (cas 1403-71-0) in the Treatment of Experimental Leishmaniasis in Hamsters09/05/2019
- Hamycin (cas 1403-71-0): Separation of toxicity and antifungal activity in mice09/04/2019
- Experimental studies (in vitro) on polyene macrolide antibiotics with special reference to Hamycin (cas 1403-71-0) against Malassezia ovale09/03/2019
- Antileishmanial activity of Hamycin (cas 1403-71-0): A polyene antibiotic09/02/2019
- Antifungal antibiotic Hamycin (cas 1403-71-0) increases susceptibility of Candida albicans to phagocytosis by murine macrophages09/01/2019


